Home
Conditions
Hypertension, Pulmonary

Clinical trial condition

Hypertension, Pulmonary

Explore clinical trials studying Hypertension, Pulmonary. Study availability and eligibility vary by location and protocol.

121 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Hypertension, Pulmonary trial results

Completed

Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.

NCT02963597

Conditions: Apnea, Cardiovascular Diseases, Dyssomnias, +13 more
Locations: Albert Einstein Healthcare Network Philadelphia, Pennsylvania, United States

Heart and Diabetes Center NRW Bad Oeynhausen, North Rhine-Westphalia, Germany

View Trial Details

Completed

Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia

NCT03092622

Conditions: Cardiovascular Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: St Olavs Hospital, Lungemedisinsk Avdeling & Hjertemedisinsk Avdeling Trondheim, Norway

View Trial Details

Completed

Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension

NCT02755259

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations: University Hospital Zurich Zurich, Switzerland

View Trial Details

Completed

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

NCT02092818

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations: Multiple Locations, Argentina

Multiple Locations, Australia

Multiple Locations, Austria

Multiple Locations, Belgium

View all 28 locations

View Trial Details

Completed

Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects

NCT03304548

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations: GSK Investigational Site Boston, Massachusetts, United States

View Trial Details

Completed

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

NCT01971450

Conditions: Behavior, Cardiovascular Diseases, Health Behavior, +8 more
Locations: Multiple Locations, Russia

View Trial Details

Completed

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

NCT02007629

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations: La Jolla, California, United States

Sacramento, California, United States

Iowa City, Iowa, United States

Boston, Massachusetts, United States

View all 27 locations

View Trial Details

Completed

A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects

NCT02688387

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients

NCT02551653

Conditions: Cardiovascular Diseases, Familial Primary Pulmonary Hypertension, Hypertension, +4 more
Locations: GSK Investigational Site London, United Kingdom

GSK Investigational Site London, United Kingdom

View Trial Details

Completed

The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH

NCT02647060

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations: National Taiwan University Hospital Taipei, Zhongzheng Dist, Taiwan

View Trial Details

Hypertension, Pulmonary

Hypertension, Pulmonary trial results

Related conditions